García-Salcido FJ, Hernández-Castellano VA, SánchezTurati JG, Saavedra-Briones DV, Merayo-Chalico CE, Camarena-Reynoso H, Fulda-Graue SD, Santana-Rios S, Urdiales-Ortiz A, Pérez BR, Ahumada-Tamayo S,Martínez JA, Fernández-Noyola G, Camacho-Castro AJ, Muñoz-Ibarra E, Cantellano-Orozco M, Morales-Montor JG, Sotomayor-Zavaleta M, Pacheco-Gahbler C

Language: Spanish
References: 12
Page: 196-199
PDF size: 450.23 Kb.

ABSTRACT

Objective: To present three cases of patients with severe Peyronie’s disease who were successfully treated with the application of porcine intestinal submucosa (Surgisis) as a surgical treatment option.
Clinical cases: Three cases of patients with Peyronie’s disease are presented who were initially managed conservatively with 300 mg vitamin E every twenty-four hours and 1 mg colchicine every twelve hours for a period of six to nine months with no clinical improvement. Surgical treatment was performed with H incision of the plaque and application of porcine intestinal submucosa for the correction of penile curvature. The three patients showed penile curvature correction by means of test with alprostadil three months after surgery.
Conclusions: The use of porcine intestinal submucosa as treatment for Peyronie’s disease has been shown to be an effective technique with low complication rate, currently making it the treatment of choice in severe cases of the disease.

REFERENCES

1. Kadioglu A, Sanli O, Akman T, et al. Graft materials in Peyronie´s disease surgery: a comprehensive review. J Sex Med 2007;4:581-95.

2. Jarow JP, Lowe FC. Penile trauma: an etiologic factor in Peyronie´s disease and erectile dysfunction. J Urol 1997;158:1388-90.

3. Chilton CP, Castle WM, Westwood CA, Pryor JP. Factors associated with the aetiology of Peyronie’s disease. Br J Urol 1982;54:748-50.

4. O’Brien K, Parker M, Guhring P, et al. An analysis of the natural history of Peyronie’s disease. J Urol 2006;175:2115-8.

5. Sikka SC, Hellstrom WJ. Role of oxidative stress and antioxidants in Peyronie´s disease. Int J Impot Res 2002;14:353-60.

6. Akkus E, Carrier S, Rehman J, et al. Is colchicine affective in Peyronie´s disease? A pilot study. Urology 1994;44:291-5.

7. Intralesional verapamil for the treatment of Peyronie´s disease a review. Int J Impot Res 2002;14:324-8.

8. Essed E, Schoeder FH: New surgical treatment for Peyronie´s disease. Urology 1985;25:582-7.

9. Yurkanin JP, Dean R, Wessells H. Effect of incision and saphenous vein grafting for Peyronie’s disease on penile length and sexual satisfaction. J Urol 2001;166:1769-72.

10. Levine LA, Estrada CR. Human cadaveric pericardial graft for the surgical correction of Peyronie’s disease. J Urol 2003;170(6Pt1):2359-62.

11. Knoll DL. Use of porcine small intestinal submucosal graft in the surgical management of Peyronie’s disease. Urology 2001;57:753-7.

12. Rutner AB, Levine SR, Schmaelzle JF. Processed porcine small intestine submucosa as a graft material for pubovaginal slings: durability and results. Urology 2003;62:805-9.